DDIT3 and adrenal gland neoplasm: Case #2 was first treated with a combination of R‐CHOP and Ibrutinib for one cycle due to adrenal glands tumors and their related high risk of central nervous system (CNS) involvement, and is now being treated with a combination of Sintilimab, R‐CHOP, and Ibrutinib.